Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Quanterix Corporation | QTRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 15.59 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.59 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 11.39 - 29.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 15.59 | USD |
Quanterix Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 593.41M | 38.06M | - | 122.37M | -32.33M | -0.85 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Quanterix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QTRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.73 | 17.075 | 15.4214 | 16.00 | 365,797 | -0.14 | -0.89% |
| 1 Month | 23.50 | 23.86 | 15.33 | 18.30 | 375,968 | -7.91 | -33.66% |
| 3 Months | 22.61 | 29.70 | 15.33 | 22.84 | 367,949 | -7.02 | -31.05% |
| 6 Months | 21.31 | 29.70 | 15.33 | 23.34 | 346,889 | -5.72 | -26.84% |
| 1 Year | 11.69 | 29.70 | 11.39 | 22.97 | 364,066 | 3.90 | 33.36% |
| 3 Years | 60.59 | 69.22 | 6.31 | 24.12 | 376,567 | -45.00 | -74.27% |
| 5 Years | 21.95 | 92.57 | 6.31 | 28.86 | 316,322 | -6.36 | -28.97% |
Quanterix Description
| Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability. |
